We're seeing a revolution in how we protect our data and systems, driven by rapidly evolving threats and the need for more sophisticated defenses.Our guest, Kelly Randis, Head of Global Information Technology at Gamida Cell Ltd., brings over three decades of IT expertise, primarily in the pharmaceutical industry. We discuss how AI is reshaping security protocols in biotech, addressing both the challenges and advancements this integration presents.We also examine the broader implications of AI in IT infrastructure and strategies companies can employ to safeguard sensitive data against an increasing array of cyber-attacks.Tune in to gain valuable insights into the critical role of technology in enhancing operational efficiency and securing data in the biotechnology sector.Specifically, this episode highlights the following themes:Integration of AI in cybersecurityBuilding robust IT infrastructures in biotechStrategies for safeguarding against phishing and ransomware attacksLinks from this episode:Get to know more about Steven Swan: https://www.linkedin.com/in/swangroupGet to know more about Kelly Randis: https://www.linkedin.com/in/kellyarandisLearn more about Gamida Cell Ltd. :https://www.gamida-cell.com

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related